Your fact-checks will appear here
Ivermectin's ability to inhibit cancer cell growth, induce apoptosis and autophagy, and suppress angiogenesis, as demonstrated in laboratory and animal studies.
Laboratory and animal studies show ivermectin can block cancer cell growth, trigger programmed cell death and alter tumor-related signaling pathways, suggesting biological plausibility as an anticance...
Preclinical evidence places and its downstream Akt/mTOR axis as the single most consistently implicated route for —especially in where ivermectin promotes ubiquitin-mediated degradation of PAK1, reduc...